AVENUE THERAPEUTICS INC (ATXI) Stock Cash Flow
NASDAQ:ATXI - Nasdaq - US05360L4032 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -9.52M | -10.49M | -3.60M | -3.73M | -5.15M | |||
| Change In Working Capital | -538.00K | -290.00K | 408.00K | -461.00K | -172.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -528.00K | 1.33M | -4.40M | 442.00K | 710.00K | |||
| OPERATING CASH FLOW | -10.59M | -9.45M | -7.60M | -3.75M | -4.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| Other Investing Activity | N/A | -3.00M | N/A | 0.00 | -1.00M | |||
| INVESTING CASH FLOW | N/A | -3.00M | N/A | 0.00 | -1.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 12.95M | 7.53M | 11.05M | 5.04M | 0.00 | |||
| Other Financing Activity | N/A | N/A | -508.00K | -663.00K | 0.00 | |||
| FINANCING CASH FLOW | 13.02M | 7.53M | 10.54M | 4.38M | 0.00 | |||
| CHANGE IN CASH | 2.44M | -4.92M | 2.94M | 631.00K | -5.61M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.59M | -9.45M | -7.60M | -3.75M | -4.61M | |||
| Capital Expenditure | N/A | N/A | N/A | N/A | N/A | |||
| FREE CASH FLOW | -10.59M | -9.45M | -7.60M | -3.75M | -4.61M | |||
All data in USD